Dentsply Beats Out PE Firms for AstraZeneca Unit

Dentsply International beat out a number of private equity firms to buy AstraZeneca’s dental implants and medical devices unit, Reuters reported. Dentsply is paying $1.8 billion in cash for the unit, Astra Tech. The unit, with revenue last year of $535 million, is the third largest dental implants maker in the world, Reuters said. A number of prominent firms were interested in buying Astra Tech, including Bridgepoint, Cinven, PAI Partners and Warburg Pincus.

22 June 2011•1 min read
Feature image
LinkedInXEmail
LinkedInXEmail

Related articles